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DOCTORS AND SOCIETY
The challenge of chronic conditions in Hong Kong
There has been a continuing epidemiological shift away
from acute diseases to more chronic illnesses in developed
countries since the 1960s. By 2020, the rank order of major
disease burden is projected to be dominated by chronic con-
ditions (Table).1 Acute diseases affecting mainly children
in developing countries are expected to decline significantly
as global immunisation reaches most countries.1 Therefore,
chronic conditions are expected to become the main cause
of morbidity and mortality worldwide, contributing two
thirds of the illness burden with enormous implications for
health resource allocation.1 The demographic transition to
an ageing society, the implementation of rapidly advancing
technologies, and the ever upward cost spiral of health care
system financing will compound the already heavy economic
toll of meeting the needs of chronically ill people.
How can health care professionals contribute to meet
this enormous challenge? The Medical and Health Research
Network of the University of Hong Kong convened a con-
sensus meeting in December 2001 to develop an evidence-
based framework for meeting this challenge. Panel members
representing a wide spectrum of stakeholders—international
agencies, local government, academic institutions, health
and welfare professionals, and patient groups— participated
in the meeting and contributed to the content of this essay.
Needs assessment and the wider determinants of
health
To provide a valid basis for such difficult policy decisions
as meeting the challenge of chronic conditions, reliable and
comprehensive data on the population health status are
needed. A new approach to measuring health status
needs to be implemented—one that quantifies not merely
mortality rates but also the impact of premature death and
disability.2 The disability-adjusted life year is such a
measure. Disability-adjusted life years express years of
life lost to premature death and years lived with a disability.
A ‘premature’ death is defined as one that occurs before
the age to which the dying person could have expected to
survive if he/she was a member of a standardised model
population with a life expectancy equal to that of the world’s
longest-surviving population, Japan. Disease burden is, in
effect, the gap between a population’s actual health status
and a reference status.1
Table. Epidemiological transition of disease
Five leading causes of death in Hong Kong Five leading causes of disability-adjusted life years worldwide1
1947 1999 1990 2020
Pneumonia Malignant neoplasms Lower respiratory tract infections Ischaemic heart disease
Tuberculosis Heart diseases Diarrhoeal diseases Unipolar major depression
Perinatal/neonatal conditions Cerebrovascular disease Perinatal conditions Road traffic accidents
Enteritis and diarrhoea Pneumonia Unipolar major depression Cerebrovascular disease
Violence Injury and poisoning Ischaemic heart disease Chronic obstructive
  pulmonary disease
Recommendation 1
There is a need to invest in systematically expanding
the public health knowledge base that will provide the
intelligence for continued health gains, through increased
funding for research and development targeted at local
priorities.
In addition to identifying the overall needs of people
with chronic diseases by studying the burden of illness,
evidence points to the persistent inequalities in health
status found within populations. This is not a problem of
absolute poverty per se and therefore restricted to develop-
ing regions but one that affects disadvantaged populations
in all communities. Even among high-income populations
such as Hong Kong, it has been shown that income inequal-
ity produces adverse health effects for people falling on the
left side of the Bell curve.3 The best approach to the reduc-
tion of inequalities is to focus on the underlying structural
determinants of social and economic deprivation.2,3
Recommendation 2
Minimising the excess burden of illness suffered by dis-
advantaged people must be a priority. Efforts should be
focused on interventions that will help lead whole commu-
nities out of an inequitable distribution of resources.
Intersectoral issues must be dealt with more effectively,
particularly health risks that result from environmental
causes in the broadest sense.
Strategies for improving clinical outcomes
Chronic conditions present different challenges from
acute diseases, thus requiring a paradigm shift in disease
management strategies. First, they are characterised by
the presence of numerous co-morbidities.4 Second, most
health care settings are poorly prepared to care for patients
with chronic disabilities.4 Third, frequent readmissions to
hospital for exacerbations or complications, the need for
long-term follow-up and medication, and the involvement
of multiple specialties are prominent features. Duplication
of investigations among disparate providers is common-
place and there is often no coordinated care leading to
sporadic and piecemeal services.5 Therefore, a more inte-
grated approach to the management of chronic diseases is
proposed.5 Essentially, all chronic disease management
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programmes involve patient and family education, pro-
motion of self-management, care process re-engineering,
adoption of evidence-based protocols, and an information
technology infrastructure to support implementation and
evaluation. This framework also includes improving care
coordination and controlling costs through integration of
services across the entire spectrum of care.5,6
Recommendation 3
Health service delivery should move away from compart-
mentalised systems focused on episodic care to an integrated
model of chronic disease management.
Moreover, primary care remains the best setting for
the treatment of patients with chronic illness. It has been
demonstrated that a strong primary care infrastructure
produces better clinical outcomes at lower costs.7 While
consistent evidence indicates that specialists are more
knowledgeable about the management of chronic
conditions,8 primary care remains the first point of contact
and the most efficient level of service. The challenge is to
ensure appropriate referrals to specialists without massive
translocation of care. Shared-care arrangements hold real
promise and should be more intensively examined.9
Recommendation 4
An integrated and patient-centred model of care delivery
should have primary care, and family medicine in particular,
as its centrepiece. Shared-care arrangements should be
further studied and tested.
Political economy in chronic disease management
Given the enormous challenge of managing chronic diseases,
the current level of politico-economic discussion about
this issue seems strangely circumscribed and muted. If
health care professionals and the public are not engaged by
these problems, bureaucrats and legislators will not have
the political will or need to address them.
Recent evidence from the World Health Organization
Commission on Macroeconomics and Health encourages a
radical rethink about the relationship between health,
economics, and politics.10 The Commission maintains that
globally, by 2020, additional health investments of US$66
billion per year will generate at least US$360 billion per
annum. Approximately half of this will be the result of
direct economic benefits and the other half a consequence
of the indirect benefits from greater individual productivity.
The commitment of increased resources may be a necessary
condition for intensifying health interventions, but the
Commission recognises that such a commitment alone will
not be sufficient—political and administrative commitments
are key co-requisites.
It is vital to consider the audience that must be convinced
by this evidence. The decisive audience is not the policy-
makers but the public, especially the substantial number of
people with chronic diseases who stand to gain or lose the
most from the politico-economic discourse of how best to
structure policies to deal with the burgeoning implications
of chronic conditions. Patients should be empowered not
only to take personal responsibility for their illnesses but,
more broadly, to take an active role in the political economy
of how best to formulate macro-level policies.
Recommendation 5
Health care professionals, policymakers, and the public
should be encouraged to actively participate in the politico-
economic discussions on policy formulation relating to
chronic disease management, supported by rigorous
evidence.
Conclusions
The burden of chronic diseases is high and will increase
further. The issues outlined constitute an agenda for Hong
Kong. Some of the latest evidence has been presented
and a series of broad recommendations for helping the
community deal with the onus of chronic conditions have
been laid out. How best to implement these measures
remains a puzzle, however, and requires the collective
wisdom and dedication of frontline workers. The tasks are
set for us.
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